ono 1078 has been researched along with Breast Neoplasms in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velázquez-Quesada, I | 1 |
| Ruiz-Moreno, AJ | 1 |
| Casique-Aguirre, D | 1 |
| Aguirre-Alvarado, C | 1 |
| Cortés-Mendoza, F | 1 |
| de la Fuente-Granada, M | 1 |
| García-Pérez, C | 1 |
| Pérez-Tapia, SM | 1 |
| González-Arenas, A | 1 |
| Segura-Cabrera, A | 1 |
| Velasco-Velázquez, MA | 1 |
1 other study available for ono 1078 and Breast Neoplasms
| Article | Year |
|---|---|
Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Chromones; Drug Screening Assays, Antitumor; Humans; Integr | 2020 |